tert-Butyl((3R,5S)-5-(hydroxymethyl)pyrrolidin-3-yl)carbamatehydrochloride
97%
- Product Code: 155022
CAS:
1264243-44-8
Molecular Weight: | 252.74 g./mol | Molecular Formula: | C₁₀H₂₁ClN₂O₃ |
---|---|---|---|
EC Number: | MDL Number: | MFCD11042661 | |
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | Room temperature, seal, dry |
Product Description:
Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of antiviral and central nervous system agents. Its chiral structure makes it valuable for creating enantiomerically pure drugs. Commonly employed in medicinal chemistry for building blocks in protease inhibitors and receptor modulators. Also utilized in research settings for structure-activity relationship studies due to its stable stereochemistry and functional group compatibility.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
100mg | 10-20 days | $290.47 |
+
-
|
250mg | 10-20 days | $474.85 |
+
-
|
1g | 10-20 days | $1,302.15 |
+
-
|
tert-Butyl((3R,5S)-5-(hydroxymethyl)pyrrolidin-3-yl)carbamatehydrochloride
Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of antiviral and central nervous system agents. Its chiral structure makes it valuable for creating enantiomerically pure drugs. Commonly employed in medicinal chemistry for building blocks in protease inhibitors and receptor modulators. Also utilized in research settings for structure-activity relationship studies due to its stable stereochemistry and functional group compatibility.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
$0.00
$0.00
Total :